High Expression of EpCAM and Sox2 is a Positive Prognosticator of Clinical Outcome for Head and Neck Carcinoma.

Abstract

Locally advanced head and neck squamous cell carcinomas (HNSCC) have limited prognosis due to frequent treatment failure. Currently, TNM-classification and human papillomavirus (HPV) infection are the sole clinical prognosticators of outcome. Tumor heterogeneity and stemness based on epithelial-mesenchymal-transition reportedly associate with therapy resistance. The capacity of epithelial marker EpCAM (EpEX), stemness regulator Sox2 and mesenchymal marker vimentin to predict clinical outcome of HSNCC patients was assessed upon immunohistochemistry staining in two cohorts of HNSCC patients treated with surgery and adjuvant radio (chemo) therapy (n = 94) and primary radio (chemo) therapy (n = 94), respectively. Prognostic values with respect to overall, disease-free and disease-specific survival were assessed in uni- and multivariate cox proportional hazard models to generate integrated risk scores. EpEX, Sox2 and vimentin displayed substantial inter- and intratumoral heterogeneity. EpEXhigh and Sox2high predicted improved clinical outcome in the discovery cohort and in the HPV-negative sub-cohort. EpEXhigh and Sox2high were confirmed as prognosticators of clinical outcome in the validation cohort treated with definitive radio(chemo)therapy. Importantly, EpEXhigh identified patients with improved survival within the HPV-negative subgroup of the validation cohort. Hence, Sox2high and particularly EpEXhigh have potential as tools to predict clinical performance of HNSCC patients, foremost HPV-negative cases, in the frame of molecular-guided treatment decision-making.

• Authors: Philipp Baumeister, Alessandra Hollmann, Julia Kitz, Artemis Afthonidou, Florian Simon, Julius Shakhtour, Brigitte Mack, Gisela Kranz, Darko Libl, Martin Leu, Markus A Schirmer, Martin Canis, Claus Belka, Horst Zitzelsberger, Ute Ganswindt, Julia Hess, Mark Jakob, Kristian Unger, Olivier Gires
• Journal: Scientific reports (Sci Rep) Vol. 8 Issue 1 Pg. 14582 (10 01 2018) ISSN: 2045-2322 [Electronic] England
• PMID: 30275505 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Biomarkers, Tumor
• EPCAM protein, human
• Epithelial Cell Adhesion Molecule
• SOX2 protein, human
• SOXB1 Transcription Factors

Topics

• Adult
• Aged
• Biomarkers, Tumor (analysis)
• Carcinoma, Squamous Cell (diagnosis, pathology, radiotherapy, surgery)
• Diagnostic Tests, Routine (methods)
• Epithelial Cell Adhesion Molecule (analysis)
• Female
• Gene Expression Profiling
• Head and Neck Neoplasms (diagnosis, pathology, radiotherapy, surgery)
• Humans
• Immunohistochemistry
• Male
• Middle Aged
• Prognosis
• SOXB1 Transcription Factors (analysis)
• Survival Analysis
• Treatment Outcome
• Young Adult